Condition: Lupus Erythematosus, Systemic · Sponsor: AstraZeneca
VIOLET is a prospective, single-arm, multi-centre, non-interventional study (NIS) evaluating real-world clinical and patient-reported outcome (PRO) data in adult patients who are initiated on subcutaneous anifrolumab treatment of systemic lupus erythematosus (SLE) in line with the applicable european summary of product characteristics (SmPC) and neither having used anifrolumab subcutaneous (SC) or intravenous (IV) before.
This description comes directly from the study's public registry record.
AstraZeneca Clinical Study Information Center · 1-877-240-9479 · information.center@astrazeneca.com
Always discuss trial participation with your own doctor first.
| Research Site | Altenburg, Germany | Recruiting |
| Research Site | Bad Bramstedt, Germany | Recruiting |
| Research Site | Berlin, Germany | Recruiting |
| Research Site | Chemnitz, Germany | Recruiting |
| Research Site | Erlangen, Germany | Recruiting |
| Research Site | Heidelberg, Germany | Recruiting |
| Research Site | Herne, Germany | Recruiting |
| Research Site | Kassel, Germany | Recruiting |
| Research Site | Leipzig, Germany | Recruiting |
| Research Site | Meerbusch-Lank, Germany | Recruiting |
| Research Site | München, Germany | Recruiting |
| Research Site | Planegg, Germany | Recruiting |
+ 4 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07424261